Open Access

Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes HUVEC sprouting through endothelin‑1

  • Authors:
    • Sang-Hun Choi
    • Min Ji Park
    • Hyunggee Kim
  • View Affiliations

  • Published online on: September 27, 2022     https://doi.org/10.3892/ol.2022.13533
  • Article Number: 413
  • Copyright: © Choi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Anti‑angiogenesis therapy, a promising remedy against tumor progression, is now widely used to treat numerous types of cancer. Since vascular endothelial growth factor (VEGF) is the most vital factor in angiogenesis, most anti‑angiogenesis drugs target the VEGF‑related pathway. However, in glioblastoma (GBM), the therapeutic strategy involving the inhibition of VEGF signaling is ineffective. The present study demonstrated that the potential angiogenic function of endothelin‑1 (EDN1) was upregulated by inhibitor of differentiation 1 (ID1) independent of VEGF during tumor angiogenesis. Anatomic structure transcriptomes of patients with GBM revealed that the expression levels of ID1 and EDN1 were specifically upregulated in the vascular‑related region. The aortic ring assay and endothelial sprouting assay demonstrated that EDN1 more potently promoted endothelial sprouting ability than VEGF. The activity of EDN1 was induced by endothelin receptor, which seemed to mediate regulation via positive feedback. Finally, in patients with GBM who did not respond to bevacizumab, a VEGF antagonist, EDN1 expression was higher than that in bevacizumab responders. Collectively, the present study demonstrated that EDN1 is a potent angiogenic factor inducing endothelial sprouting and may be a novel target for inhibiting glioma angiogenesis.
View Figures
View References

Related Articles

Journal Cover

November-2022
Volume 24 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Choi S, Park MJ and Kim H: Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes HUVEC sprouting through endothelin‑1. Oncol Lett 24: 413, 2022.
APA
Choi, S., Park, M.J., & Kim, H. (2022). Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes HUVEC sprouting through endothelin‑1. Oncology Letters, 24, 413. https://doi.org/10.3892/ol.2022.13533
MLA
Choi, S., Park, M. J., Kim, H."Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes HUVEC sprouting through endothelin‑1". Oncology Letters 24.5 (2022): 413.
Chicago
Choi, S., Park, M. J., Kim, H."Inhibitor of differentiation 1 in U87MG glioblastoma cells promotes HUVEC sprouting through endothelin‑1". Oncology Letters 24, no. 5 (2022): 413. https://doi.org/10.3892/ol.2022.13533